Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of human DUS4L gene and related product of human DUS4L gene

A technology of genes and uses, which can be used in medical preparations containing active ingredients, genetic engineering, plant genetic improvement, etc., and can solve problems such as lack of DUS4L gene

Active Publication Date: 2020-03-31
LANZHOU UNIVERSITY +1
View PDF6 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] At present, there is no relevant report on the use of DUS4L gene in the treatment of lung cancer

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of human DUS4L gene and related product of human DUS4L gene
  • Application of human DUS4L gene and related product of human DUS4L gene
  • Application of human DUS4L gene and related product of human DUS4L gene

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0103] Example 1 Preparation of RNAi lentivirus against human DUS4L gene

[0104] 1. Screening for effective siRNA targets against the human DUS4L gene

[0105] Retrieve DUS4L (NM_181581) gene information from Genbank; design effective siRNA targets for DUS4L gene. Table 1-1 lists the screened effective siRNA target sequences against the DUS4L gene.

[0106] Table 1-1 is targeted at the siRNA target sequence of human DUS4L gene

[0107] SEQ ID NO TargetSeq(5'-3') 1 ACATCAGCAATCATAGATT

[0108] 2. Preparation of lentiviral vector

[0109] Aim at the siRNA target (take SEQ ID NO: 1 as an example) to synthesize a double-stranded DNA Oligo sequence (Table 1-2) with Age I and EcoR I restriction sites at both ends; Dicer acts on the pGCSIL-GFP vector (provided by Shanghai Jikai Gene Chemical Technology Co., Ltd.) to linearize it, and agarose gel electrophoresis identifies the digested fragment.

[0110] Table 1-2 Double-stranded DNA Oligo with sticky ends ...

Embodiment 2

[0129] Example 2 Real-time fluorescent quantitative RT-PCR method to detect gene silencing efficiency

[0130] Human lung cancer A549 cells in the logarithmic growth phase were digested with trypsin to make a cell suspension (the number of cells was about 5×10 4 / ml) were inoculated in a 6-well plate and cultured until the cell confluency reached about 30%. According to the multiplicity of infection (MOI, A549:10), an appropriate amount of the lentivirus prepared in Example 1 was added, and the culture medium was replaced after 24 hours of culture. After the infection time reached 5 days, the cells were collected. Total RNA was extracted according to the instruction manual of Invitrogen's Trizol. According to the M-MLV instruction manual of Promega Company, RNA was reverse-transcribed to obtain cDNA (see Table 2-1 for the reverse transcription reaction system, react at 42°C for 1 hour, and then bathe in a water bath at 70°C for 10 minutes to inactivate the reverse transcripta...

Embodiment 3

[0137] Embodiment 3Western Blotting method detects the silencing efficiency of gene

[0138] 1. Extraction of total cell protein

[0139] (1) Infect the target cells (A549 cells) with the control virus and the RNAi virus targeting the DUS4L interference target respectively. Cell samples were received and washed twice with PBS. Take an appropriate amount of RIPA lysate, add PMSF within a few minutes before use, so that the final concentration of PMSF is 1mM. (use RIPA lysate, instruction link: http: / / www.beyotime.com / ripa- analysis-bufferm.htm )

[0140] (2) Add an appropriate amount of RIPA lysate, and lyse on ice for 10-15 minutes. Scrape the cells and transfer them into a new EP tube, and then ultrasonically disrupt the cells (20 times at 40W, 1 s each time, 2 s apart).

[0141] (3) 4°C, 12000g, centrifuge for 15min, take the supernatant to determine the protein concentration by BCA method (link to BCA Protein Assay Kit manual: http: / / www.beyotime.com / p0010s.htm)

...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the field of biomedicine research, and specifically relates to an application of a human DUS4L gene as a target in preparation of a lung cancer therapeutic drug. Through extensive and in-depth research, results find that after an RNAi method is used to down-regulate the expression of the human DUS4L gene, proliferation of lung cancer cells can be effectively inhibited, cell apoptosis can be promoted, and the growth process of lung cancer can be effectively controlled. An siRNA or a nucleic acid construct containing an siRNA sequence and lentivirus provided by the invention can specifically inhibit the proliferation ability of the lung cancer cells, inhibit cloning of the lung cancer cells, affect a cycle of the lung cancer cells, promote apoptosis of the lung cancer cells, and inhibit growth of the lung cancer cells, thereby treating the lung cancer and opening up a novel direction for treatment of the lung cancer.

Description

technical field [0001] The invention belongs to the field of biomedical research, and specifically relates to the use of human DUS4L gene and related products. Background technique [0002] DUS4L is a protein-coding gene. Gene Ontology (GO) annotations associated with this gene included oxidoreductase activity and FMN binding. DUS4L-BCAP29 fusion gene appears in various tissue samples (Recurrent fusionRNA DUS4L-BCAP29 in non-cancer human tissues and cells. Tang Y, Qin F, Liu A, LiH. Oncotarget. 2017May 9; 8(19): 31415 -31423.doi:10.18632 / oncotarget.16329.). And it was reported that the DUS4L-BCAP29 fusion gene was significantly overexpressed when inducing human umbilical cord mesenchymal stem cells to undergo neural differentiation (Identification of chimeric RNAs in human infant brains and their implications in neural differentiation. Tang Y, et al. Int J Biochem CellBiol. 2019 Jun; 111:19-26. doi:10.1016 / j.biocel.2019.03.012. Epub 2019Apr 5). [0003] Lung cancer is th...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12Q1/6886C12N15/113C12N15/867A61K45/00A61K31/713A61P35/00A61P11/00
CPCC12Q1/6886C12N15/1137C12N15/86A61K45/00A61P35/00A61P11/00C12Q2600/136C12Q2600/158C12N2310/14C12N2740/15043C12N2800/107C12N2310/531Y02A50/30
Inventor 李斌
Owner LANZHOU UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com